Ubiquitin, TAK1 and IKK: is there a connection?
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Inflammatory signals such as LPS, pro-inflammatory cytokines, reactive oxygen species, advanced glycation end products, and oxidized LDL cause IKKβ phosphorylation; this phosphorylates IκBα, leading to its ubiquitination and degradation, which releases NF-κB to enter the nucleus and induce pro-inflammatory genes.
“Extracellular inflammatory signals including lipopolysaccharide (LPS), pro-inflammatory cytokines, reactive oxygen species, advanced glycation end products, and oxidized low-density lipoprotein trigger the phosphorylation of IKKβ, which in turn phosphorylates IκBα for ubiquitination and degradation by proteasome [13–18].”
From Edible blue-green algae reduce the production of pro-inflammatory cytokines by inhibiting NF-κB pathway in macrophages and splenocytes (2013) · cites this paper as [14]
Cites
Baeuerle, P. A., & Baltimore, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81318-5 · Cited by 3,002 · see citing works
TAK1 is a ubiquitin-dependent kinase of MKK and IKK
Wang, C., Deng, L., Hong, M., Akkaraju, G. R., Inoue, J.-I., & Chen, Z. J. (2001) · Nature · doi:10.1038/35085597 · Cited by 2,125 · see citing works
Self-citationDeng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaughter, C., Pickart, C., & Chen, Z. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00126-4 · Cited by 1,872 · see citing works
Self-citationDe-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
Wertz, I. E., O’Rourke, K. M., Zhou, H., Eby, M. T., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R. T., Boone, D. L., et al. (2004) · Nature · doi:10.1038/nature02794 · Cited by 1,852 · see citing works
Identification of a Member of the MAPKKK Family as a Potential Mediator of TGF-β Signal Transduction
Yamaguchi, T., Shirakabe, K., Shibuyà, H., Irie, K., Oishi, I., Ueno, N., Taniguchi, T., Nishida, E., & Matsumoto, K. (1995) · Science · doi:10.1126/science.270.5244.2008 · Cited by 1,344 · see citing works
Ninomiya‐Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J., Cao, Z., & Matsumoto, K. (1999) · Nature · doi:10.1038/18465 · Cited by 1,187 · see citing works
The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB Signal
Kelliher, M. A., Grimm, S., Ishida, Y., Kuo, F., Stanger, B. Z., & Leder, P. (1998) · Immunity · doi:10.1016/s1074-7613(00)80535-x · Cited by 1,102 · see citing works
The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination
Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israël, A., Wallach, D., & Courtois, G. (2003) · Nature · doi:10.1038/nature01802 · Cited by 1,018 · see citing works
CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members
Trompouki, E., Hatzivassiliou, E., Tsichritzis, T., Farmer, H., Ashworth, A., & Mosialos, G. (2003) · Nature · doi:10.1038/nature01803 · Cited by 964 · see citing works
Site-Specific Phosphorylation of IκBα by a Novel Ubiquitination-Dependent Protein Kinase Activity
Chen, Z. J., Parent, L. A., & Maniatis, T. (1996) · Cell · doi:10.1016/s0092-8674(00)81064-8 · Cited by 958 · see citing works
Self-citationLoss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB
Brummelkamp, T. R., Nijman, S. M. B., Dirac, A. M. G., & Bernards, R. (2003) · Nature · doi:10.1038/nature01811 · Cited by 947 · see citing works
Hofmann, R. M., & Pickart, C. M. (1999) · Cell · doi:10.1016/s0092-8674(00)80575-9 · Cited by 815 · see citing works
Yeh, W., Shahinian, A., Speiser, D. E., Kraunus, J., Billia, F., Wakeham, A. C., de la Pompa, J. L., Ferrick, D. A., Hum, B., Iscove, N. N., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80391-x · Cited by 798 · see citing works
TAB1: An Activator of the TAK1 MAPKKK in TGF-β Signal Transduction
Shibuyà, H., Yamaguchi, T., Shirakabe, K., Tonegawa, A., Gotoh, Y., Ueno, N., Irie, K., Nishida, E., & Matsumoto, K. (1996) · Science · doi:10.1126/science.272.5265.1179 · Cited by 587 · see citing works
Bcl10 activates the NF-κB pathway through ubiquitination of NEMO
Zhou, H., Wertz, I. E., O’Rourke, K. M., Ultsch, M. H., Seshagiri, S., Eby, M. T., Xiao, W., & Dixit, V. M. (2003) · Nature · doi:10.1038/nature02273 · Cited by 527 · see citing works
Recruitment of TNF Receptor 1 to Lipid Rafts Is Essential for TNFα-Mediated NF-κB Activation
Legler, D. F., Micheau, O., Doucey, M., Tschopp, J., & Bron, C. (2003) · Immunity · doi:10.1016/s1074-7613(03)00092-x · Cited by 464 · see citing works
Recruitment of the IKK Signalosome to the p55 TNF Receptor
Zhang, S. Q., Kovalenko, A., Cantarella, G., & Wallach, D. (2000) · Immunity · doi:10.1016/s1074-7613(00)80183-1 · Cited by 456 · see citing works
Lee, S. Y., Reichlin, A., Santana, A., Sokol, K. A., Nussenzweig, M. C., & Choi, Y. (1997) · Immunity · doi:10.1016/s1074-7613(00)80390-8 · Cited by 445 · see citing works
Zhou, H., Du, M., & Dixit, V. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.012 · Cited by 140 · see citing works
Cannons, J. L., Bertram, E. M., & Watts, T. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.2828 · Cited by 25 · see citing works
Flagged first, then by citations
1 of the 21 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,814 · see citing works
Haas, T. L., Emmerich, C. H., Gerlach, B., Schmukle, A. C., Cordier, S. M., Rieser, E., Feltham, R., Vince, J. E., Warnken, U. H., Wenger, T., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.10.013 · Cited by 768 · see citing works
The Molecular Bases of Training Adaptation
Coffey, V. G., & Hawley, J. A. (2007) · Sports Medicine · doi:10.2165/00007256-200737090-00001 · Cited by 756 · see citing works
Perkins, N. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209937 · Cited by 674 · see citing works
Vallabhapurapu, S., Matsuzawa, A., Zhang, W., Tseng, P., Keats, J. J., Wang, H., Vignali, D. A. A., Bergsagel, P. L., & Karin, M. (2008) · Nature Immunology · doi:10.1038/ni.1678 · Cited by 605 · see citing works
Direct activation of protein kinases by unanchored polyubiquitin chains
Xia, Z.-P., Sun, L., Chen, X., Pineda, G., Jiang, X., Adhikari, A., Zeng, W., & Chen, Z. J. (2009) · Nature · doi:10.1038/nature08247 · Cited by 570 · see citing works
Self-citationUbiquitin-mediated activation of TAK1 and IKK
Adhikari, A., Xu, M., & Chen, Z. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210413 · Cited by 455 · see citing works
Self-citationNF-κB in inflammation and renal diseases
Zhang, H., & Sun, S.-C. (2015) · Cell & Bioscience · doi:10.1186/s13578-015-0056-4 · Cited by 383 · see citing works
Cell type-specific function of TAK1 in innate immune signaling
Alagbala, A. A., Wang, H. Y., & Wang, R. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.03.007 · Cited by 372 · see citing works
IκB kinase β (IKKβ/IKK2/IKBKB)—A key molecule in signaling to the transcription factor NF-κB
Schmid, J. A., & Birbach, A. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.01.006 · Cited by 260 · see citing works
Role of nuclear factor κB in cardiovascular health and disease
der Heiden, K. V., Cuhlmann, S., Luong, L. A., Zakkar, M., & Evans, P. C. (2010) · Clinical Science · doi:10.1042/cs20090557 · Cited by 236 · see citing works
Wu, Z.-H., Wong, E. T., Shi, Y., Niu, J., Chen, Z. J., Miyamoto, S., & Tergaonkar, V. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.010 · Cited by 207 · see citing works
Self-citationFerch, U., Kloo, B., Gewies, A., Pfänder, V., Düwel, M., Peschel, C., Krappmann, D., & Ruland, J. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20091167 · Cited by 202 · see citing works
Cell Signaling and Function Organized by PB1 Domain Interactions
Moscat, J., Díaz-Meco, M. T., Albert, A., & Campuzano, S. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.08.002 · Cited by 195 · see citing works
Roles of NF-κB in health and disease: mechanisms and therapeutic potential
Wong, E. T., & Tergaonkar, V. (2009) · Clinical Science · doi:10.1042/cs20080502 · Cited by 195 · see citing works
Angot, A., Vergunst, A. C., Genin, S., & Peeters, N. M. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030003 · Cited by 176 · see citing works
Coordinating TLR‐activated signaling pathways in cells of the immune system
Banerjee, A., & Gerondakis, S. (2007) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100098 · Cited by 163 · see citing works
TAK1-dependent Signaling Requires Functional Interaction with TAB2/TAB3
Besse, A., Lamothe, B., Campos, A. D., Webster, W. K., Maddineni, U., Lin, S., Wu, H., & Darnay, B. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608867200 · Cited by 145 · see citing works
Mukherjee, S., Hao, Y.-H., & Orth, K. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.03.007 · Cited by 141 · see citing works
Leulier, F., Lhocine, N., Lemaître, B., & Meier, P. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00548-06 · Cited by 136 · see citing works
Current concepts of IgE regulation and impact of genetic determinants
Potaczek, D. P., & Kabesch, M. (2012) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2011.03953.x · Cited by 124 · see citing works
Alford, K. A., Glennie, S. J., Turrell, B. R., Rawlinson, L. M., Saklatvala, J., & Dean, J. L. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610987200 · Cited by 123 · see citing works
Phosphorylation and ubiquitination of the IκB kinase complex by two distinct signaling pathways
Shambharkar, P. B., Blonska, M., Pappu, B. P., Li, H., You, Y., Sakurai, H., Darnay, B. G., Hara, H., Penninger, J. M., & Lin, X. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601622 · Cited by 122 · see citing works
Fukushima, T., Matsuzawa, S., Kress, C. L., Bruey, J. M., Krajewska, M., Lefebvre, S., Zapata, J. M., Ronai, Z. A., & Reed, J. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700548104 · Cited by 114 · see citing works
Nighot, M., Rawat, M., Al–Sadi, R., Castillo, E. F., Nighot, P. K., & Ma, T. Y. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.12.016 · Cited by 111 · see citing works
Ku, C. S., Pham, T. X., Park, Y., Kim, B., Shin, M. S., Kang, I., & Lee, J. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.01.018 · Cited by 109 · see citing works
An, S., Zhao, L., She, Z., Wang, S., Zhang, K., Yu, Q., Zheng, J., Zhang, X., Zhu, X., Bao, R., et al. (2017) · Hepatology · doi:10.1002/hep.29375 · Cited by 104 · see citing works
Omori, E., Morioka, S., Matsumoto, K., & Ninomiya‐Tsuji, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804513200 · Cited by 99 · see citing works
TAK1 Is a Central Mediator of NOD2 Signaling in Epidermal Cells
Kim, J., Omori, E., Matsumoto, K., Núñez, G., & Ninomiya‐Tsuji, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704746200 · Cited by 98 · see citing works
Sustained oxidative stress inhibits NF-κB activation partially via inactivating the proteasome
Wu, M., Bian, Q., Liu, Y., Fernandes, A. F., Taylor, A., Pereira, P., & Shang, F. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.09.021 · Cited by 97 · see citing works
Kim, S. I., Kwak, J. H., Na, H.-J., Kim, J. K., Ding, Y., & Choi, M. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.007146 · Cited by 87 · see citing works
Srivastav, S., Kar, S., Chande, A. G., Mukhopadhyaya, R., & Das, P. K. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102845 · Cited by 85 · see citing works
Mao, R., Fan, Y., Mou, Y., Zhang, H., Fu, S., & Yang, J. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.09.006 · Cited by 73 · see citing works
Wu, X., & Sun, S. (2007) · EMBO Reports · doi:10.1038/sj.embor.7400931 · Cited by 72 · see citing works
Lou, H., & Kaplowitz, N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706145200 · Cited by 71 · see citing works
Inagaki, M., Omori, E., Kim, J.-Y., Komatsu, Y., Scott, G., Ray, M. K., Yamada, G., Matsumoto, K., Mishina, Y., & Ninomiya-Tsuji, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807574200 · Cited by 68 · see citing works
HIV-1 Vpr stimulates NF-κB and AP-1 signaling by activating TAK1
Liu, R., Lin, Y., Jia, R., Geng, Y., Liang, C., Tan, J., & Qiao, W. (2014) · Retrovirology · doi:10.1186/1742-4690-11-45 · Cited by 66 · see citing works
Sánchez‐Duffhues, G., Calzado, M. A., de Vinuesa, A. G., Appendino, G., Fiebich, B. L., Loock, U., Lefarth‐Risse, A., Krohn, K., & Muñóz, E. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.01.004 · Cited by 65 · see citing works
Rosato, R. R., Kolla, S. S., Hock, S. K., Almenara, J. A., Patel, A. K., Amin, S., Atadja, P. W., Fisher, P. B., Dent, P., & Grant, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.095208 · Cited by 64 · see citing works
RetractedSrivastava, A. K., Qin, X., Wedhas, N., Arnush, M., Linkhart, T. A., Chadwick, R. B., & Kumar, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705329200 · Cited by 63 · see citing works
Human Trim5α has additional activities that are uncoupled from retroviral capsid recognition
Tareen, S. U., & Emerman, M. (2010) · Virology · doi:10.1016/j.virol.2010.09.018 · Cited by 63 · see citing works
Jin, W., Chang, M., & Sun, S. (2012) · Cellular and Molecular Immunology · doi:10.1038/cmi.2011.60 · Cited by 60 · see citing works
Shang, F., & Taylor, A. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.04.001 · Cited by 60 · see citing works
Essential role of TAK1 in regulating mantle cell lymphoma survival
Buglio, D., Palakurthi, S. S., Byth, K. F., Vega, F., Toader, D., Saeh, J. C., Neelapu, S. S., & Younes, A. (2012) · Blood · doi:10.1182/blood-2011-07-369397 · Cited by 59 · see citing works
The Lysosomal Transmembrane Protein 9B Regulates the Activity of Inflammatory Signaling Pathways
Dodeller, F., Gottar, M., Huesken, D., Iourgenko, V., & Cenni, B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801908200 · Cited by 58 · see citing works
Omori, E., Inagaki, M., Mishina, Y. M., Matsumoto, K., & Ninomiya‐Tsuji, J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116188109 · Cited by 55 · see citing works
TAB4 Stimulates TAK1-TAB1 Phosphorylation and Binds Polyubiquitin to Direct Signaling to NF-κB
Prickett, T. D., Ninomiya‐Tsuji, J., Broglie, P. M., Muratore‐Schroeder, T. L., Shabanowitz, J., Hunt, D. F., & Brautigan, D. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800943200 · Cited by 49 · see citing works
TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy
Fan, Y., Cheng, J., Vasudevan, S. A., Patel, R. H., Li, L., Xu, X. Y., Zhao, Y., Jia, W., Lu, F., Zhang, H., et al. (2013) · APOPTOSIS · doi:10.1007/s10495-013-0864-0 · Cited by 49 · see citing works
TAK1 kinase determines TRAIL sensitivity by modulating reactive oxygen species and cIAP
Morioka, S., Omori, E., Kajino, T., Kajino‐Sakamoto, R., Matsumoto, K., & Ninomiya‐Tsuji, J. (2009) · Oncogene · doi:10.1038/onc.2009.110 · Cited by 49 · see citing works
Comprehending the complex connection between PKCβ, TAK1, and IKK in BCR signaling
Shinohara, H., & Kurosaki, T. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00836.x · Cited by 48 · see citing works
Chen, K., Li, L., Li, C., Wang, Y., Yang, F., Kuang, M., & Wang, G. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3187972 · Cited by 47 · see citing works
NF-κB as a Target for Oncogenic Viruses
Sun, S., & Cesarman, E. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_108 · Cited by 45 · see citing works
TAK1 ubiquitination regulates doxorubicin-induced NF-κB activation
Liang, L., Fan, Y., Cheng, J., Cheng, D., Zhao, Y., Cao, B., Ma, L., An, L., Jia, W., Xu, S., et al. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.09.003 · Cited by 44 · see citing works
Wang, Z., Yang, Y., Yang, H., Capó‐Aponte, J. E., Tachado, S. D., Wolosin, J. M., & Reinach, P. S. (2011) · PubMed Central · Cited by 43 · see citing works
Japonicone A Suppresses Growth of Burkitt Lymphoma Cells through Its Effect on NF-κB
Li, X., Yang, X., Liu, Y., Gong, N., Yao, W., Chen, P., Qin, J., Jin, H., Li, J., Chu, R., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3258 · Cited by 42 · see citing works
DDX3 Participates in Translational Control of Inflammation Induced by Infections and Injuries
Ku, Y.-C., Lai, M.-H., Lo, C.-C., Cheng, Y., Qiu, J.-T. T., Tarn, W., & Lai, M. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00285-18 · Cited by 42 · see citing works
Pang, H.-Y., Liu, G., & Liu, G.-T. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2008.29 · Cited by 39 · see citing works
Effect of High-Frequency Resistance Exercise on Adaptive Responses in Skeletal Muscle
Coffey, V. G., Reeder, D. W., Lancaster, G. I., Yeo, W. K., Febbraio, M. A., Yaspelkis, B. B., & Hawley, J. A. (2007) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31815729b6 · Cited by 39 · see citing works
Roles of TRAF6 in CD40 signaling
Hostager, B. S. (2007) · Immunologic Research · doi:10.1007/s12026-007-0082-3 · Cited by 39 · see citing works
Wang, J.-S., Wu, D., Huang, D.-Y., & Lin, W. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0182-7 · Cited by 38 · see citing works
Romero, N., Waesberghe, C. V., & Favoreel, H. W. (2020) · Journal of Virology · doi:10.1128/jvi.00196-20 · Cited by 34 · see citing works
SMYD2‐mediated TRAF2 methylation promotes the NF‐κB signaling pathways in inflammatory diseases
Wu, W., Wang, J., Xiao, C., Su, Z., Su, H., Zhong, W., Mao, J., Liu, X., & Zhu, Y. Z. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.591 · Cited by 33 · see citing works
IL-6 Induction by TNFα and IL-1β in an Osteoblast-Like Cell Line
Furia, A., Confalone, E., & D’Alessio, G. (2010) · International Journal of Biomedical Science · doi:10.59566/ijbs.2010.6135 · Cited by 33 · see citing works
Withaferin A disrupts ubiquitin-based NEMO reorganization induced by canonical NF-κB signaling
Jackson, S. S., Oberley, C. C., Hooper, C., Grindle, K. M., Wuerzberger‐Davis, S. M., Wolff, J., McCool, K. W., Rui, L., & Miyamoto, S. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.09.034 · Cited by 33 · see citing works
HSCARG downregulates NF-κB signaling by interacting with USP7 and inhibiting NEMO ubiquitination
Li, T., Guan, J., Li, S.-Z., Zhang, X., & Zheng, X. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.197 · Cited by 32 · see citing works
Epithelial Cell Death and Inflammation in Skin
Kumari, S., & Pasparakis, M. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_466 · Cited by 31 · see citing works
Pan, M., Chang, H., Wu, Y., Huang, C.-C., & Hung, W.-C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806223200 · Cited by 31 · see citing works
Karagounis, L. G., Yaspelkis, B. B., Reeder, D. W., Lancaster, G. I., Hawley, J. A., & Coffey, V. G. (2010) · European Journal of Applied Physiology · doi:10.1007/s00421-010-1427-5 · Cited by 30 · see citing works
POPX2 phosphatase regulates apoptosis through the TAK1-IKK-NF-κB pathway
Weng, T., & Koh, C.-G. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.443 · Cited by 29 · see citing works
Bottero, V., Kerur, N., Sadagopan, S., Patel, K., Sharma-Walia, N., & Chandran, B. (2010) · Journal of Virology · doi:10.1128/jvi.01911-10 · Cited by 29 · see citing works
PGC‐1β suppresses saturated fatty acid‐induced macrophage inflammation by inhibiting TAK1 activation
Chen, H., Liu, Y., Li, D., Song, J., & Xia, M. (2016) · IUBMB Life · doi:10.1002/iub.1470 · Cited by 28 · see citing works
HTLV-1 Tax-mediated TAK1 activation involves TAB2 adapter protein
Yu, Q., Minoda, Y., Yoshida, R., Yoshida, H., Iha, H., Kobayashi, T., Yoshimura, A., & Takaesu, G. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.172 · Cited by 28 · see citing works
Role of the Ubiquitin–Proteasome in Protein Quality Control and Signaling
Shang, F., & Taylor, A. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397863-9.00010-9 · Cited by 28 · see citing works
Resistance exercise and skeletal muscle: protein synthesis, degradation, and controversies
Ji, F., Lee, H. S., & Kim, J.-H. (2025) · European Journal of Applied Physiology · doi:10.1007/s00421-025-05832-z · Cited by 26 · see citing works
Activated Macrophage Survival Is Coordinated by TAK1 Binding Proteins
Mihaly, S. R., Morioka, S., Ninomiya‐Tsuji, J., & Takaesu, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094982 · Cited by 26 · see citing works
TAK1 inhibitor 5Z-7-oxozeaenol sensitizes cervical cancer to doxorubicin-induced apoptosis
Guan, S., Lu, J., Zhao, Y., Woodfield, S. E., Zhang, H., Xu, X. Y., Yu, Y., Zhao, J., Bieerkehazhi, S., Liang, H., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16895 · Cited by 25 · see citing works
Lluis, J. M., Nachbur, U., Cook, W. D., Gentle, I. E., Moujalled, D. M., Moulin, M., Wong, W. W.-L., Khan, N. R., Chau, D., Callus, B. A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008620 · Cited by 24 · see citing works
Wu, Y., Starzinski‐Powitz, A., & Guo, S. (2010) · Gynecologic and Obstetric Investigation · doi:10.1159/000279324 · Cited by 23 · see citing works
Zhang, Z., Yang, Z., Wang, S., Wang, X., & Mao, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117367 · Cited by 21 · see citing works
Zhang, J., Gao, F., & Xie, J. (2021) · Immunity Inflammation and Disease · doi:10.1002/iid3.417 · Cited by 20 · see citing works
A20 Inhibits LPS-Induced Inflammation by Regulating TRAF6 Polyubiquitination in Rainbow Trout
Jang, J. H., Kim, H. J., Jung, I. Y., & Cho, J. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189801 · Cited by 19 · see citing works
Cianni, F. D., Campa, D., Tallaro, F., Rizzato, C., Rango, F. D., Barale, R., Passarino, G., Canzian, F., Gemignani, F., Montesanto, A., et al. (2012) · AGE · doi:10.1007/s11357-012-9416-8 · Cited by 18 · see citing works
Cuadrado, I., Cidre‐Aranaz, F., Herránz, S., Estévez‐Braun, A., Heras, B. D. L., & Hortelano, S. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.10.013 · Cited by 17 · see citing works
The Biology of A20-Like Molecules
Enesa, K., & Evans, P. C. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-0398-6_3 · Cited by 17 · see citing works
Poplutz, M. K., Levikova, M., Lüscher‐Firzlaff, J., Lesina, M., Algül, H., Lüscher, B., & Huber, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-04890-4 · Cited by 17 · see citing works
Wen, X., Qin, J., Zhang, X., Ye, L., Wang, Y., Yang, R., Di, Y., He, W., & Wang, Z. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216644 · Cited by 16 · see citing works
An F-box protein, FBXW5, negatively regulates TAK1 MAP3K in the IL-1β signaling pathway
Minoda, Y., Sakurai, H., Kobayashi, T., Yoshimura, A., & Takaesu, G. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.052 · Cited by 16 · see citing works
Cho, Y.-C., Vuong, H. L., Ha, J., Lee, S., Park, J., Wibow, A. E., & Cho, S. (2020) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x20500548 · Cited by 15 · see citing works
Kim, S. H., Byun, J., Jung, S., Kim, B., Lee, K., Jeon, H., Lee, J., Choi, H. S., Kim, E. S., Jeen, Y., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10112693 · Cited by 15 · see citing works
Edwards, K. A., Motamedi, V., Osier, N. D., Kim, H., Yun, S., Cho, Y., Lai, C., Dell, K. C., Carr, W. S., Walker, P., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00091 · Cited by 15 · see citing works
Takaesu, G., Inagaki, M., Takubo, K., Mishina, Y. M., Hess, P. R., Dean, G. A., Yoshimura, A., Matsumoto, K., Suda, T., & Ninomiya‐Tsuji, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051073 · Cited by 14 · see citing works
TAK1 Inhibitor Enhances the Therapeutic Treatment for Glioblastoma
Campolo, M., Lanza, M., Casili, G., Paterniti, I., Filippone, A., Caffo, M., Cardali, S. M., Puliafito, I., Colarossi, C., Raciti, G., et al. (2020) · Cancers · doi:10.3390/cancers13010041 · Cited by 14 · see citing works
Liao, C., Zhou, H., Chen, H., Guo, C., Li, S., Ma, F., Yang, X., Xie, B., & Zhang, W. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109284 · Cited by 13 · see citing works
Chiou, W., Chen, C., Lin, I.-H., Chiu, J., & Chen, Y. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.12.022 · Cited by 12 · see citing works
Yang, X. Y., Ai, Y., Chen, L., Wang, C., Liu, J., Zhang, J., Li, J., Wu, H. M., Xiao, J., Chang, M., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.999219 · Cited by 12 · see citing works
Partners in crime: POPX2 phosphatase and its interacting proteins in cancer
Kim, P. R., Zhang, S., Rahmat, M. B. B., & Koh, C.-G. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03061-0 · Cited by 10 · see citing works
Joo, E., Fukushima, T., Harada, N., Reed, J. C., Matsuzawa, S.-I., & Inagaki, N. (2016) · Scientific Reports · doi:10.1038/srep35983 · Cited by 9 · see citing works
USP13 ameliorates nonalcoholic fatty liver disease through inhibiting the activation of TAK1
Tang, M. M., Cao, H., Ma, Y., Yao, S., Wei, X., Tan, Y., liu, F., Peng, Y., & Fan, N. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05465-4 · Cited by 8 · see citing works
The Emerging Role of OTUB2 in Diseases: From Cell Signaling Pathway to Physiological Function
Li, J., Zhang, N., Li, M., Hong, T., Meng, W., & Ouyang, T. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.820781 · Cited by 7 · see citing works
Zhang, J., Li, B., Wu, H., Ou, J., Wei, R., Liu, J., Cai, W., Liu, X., Zhao, S., Yang, J., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-3832-1 · Cited by 7 · see citing works
- Authors
- Chen, Z. J., Bhoj, V, & Seth, R. B.
- Affiliations
- Howard Hughes Medical Institute (US)
- Corresponding author
- Chen, Z J
- ORCID
- Bhoj, V
- Venue
- Cell Death & Differentiation
- Published
- 2006-02-17
- Volume
- 13
- Issue
- 5
- Pages
- 687-692
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- OpenAlex
- W1992744008
- Cited by
- 115
- References
- 21
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 4 · 2023: 1 · 2022: 6 · 2021: 3 · 2020: 5 · 2019: 4 · 2018: 1 · 2017: 5 · 2016: 2 · 2015: 5 · 2014: 5 · 2013: 4 · 2012: 10
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cell Death and Differentiation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Burroughs Wellcome Fund
- National Institutes of Health
- National Institute of General Medical Sciences (R01GM063692, R01 GM63692)
- National Institute of Allergy and Infectious Diseases (R01-AI 60919, R01AI060919)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- NF-κB signaling, TAK1, IKK activation, ubiquitination, TRAF6, E3 ubiquitin ligase, polyubiquitin chains, IκB kinase, TNF signaling, IL-1β signaling
- MeSH terms
- MAP Kinase Kinase Kinase 7, Animals, Enzyme Activation, Gene Expression Regulation, Immunity, Active, Immunity, Innate, Interleukin-1, Models, Biological, Tumor Necrosis Factor-alpha, Signal Transduction, MAP Kinase Kinase Kinases, Ubiquitin, I-kappa B Kinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review